1Leonardo P, Teodoro DS, Andrea G. Efficacy and safety of nimodipine in subcortical vascular dementia. A randomized placebo-controlled trial [ J ]. Stroke, 2005,36(3) :619-624. 被引量：1
2Lopez-Arrieta, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia[J]. Cochrane Database of Syst Rev,2002:CD000147. 被引量：1
1[1]Roger P,Simon,Michael J.Aminoff David A.Greenberg.Clinical Neurlolgy.fourth edition.McGraw-Hill,2000,274-308 被引量：1
2[2]European Stroke Initiative (EUSI).Recommendations for Stroke Managemen.Acute Treatment of Ischemic Stroke.Cerebrosvascular Diseases,2000,10(suppl 3):22-33 被引量：1
3[3]A production of the National Stroke Association.Stroke-the first hours Guidelines for Acute Treatment.2000 National Stroke Association,2000,1-16 被引量：1
4[4]International Consensus on Science.The era of reperfusion:section 2:acute stroke.Circulation,2000,102(suppl):204-216 被引量：1
6[6]Alberts MJ.TPA in acute ischemic stroke:united States experience and issues for the future.Neurology,1998,51(suppl):53-55 被引量：1
7[7]Schroeder EB,Rosamond WD,Morris DL,et al.Determinants of Use of Emergency Medical Services in a Population with Stroke Symptoms.Stroke,2000,31:2591-2596 被引量：1
8[8]South African Medical Association-Neurological Association of South Afric Stroke Working Group.Stroke Therapy Clinical Guideline.SAMJ,2000,90(3):276-306 被引量：1
